NasdaqGS:VTRSPharmaceuticals
Viatris (VTRS) Stock Trades At A Discount To Sales Despite A 76% Run
Viatris stock has returned 76.1% over the past year, yet its valuation checks still lean cheap, which puts the recent share price strength under scrutiny for investors trying to judge whether the current level around US$16.43 offers enough long term value support.
Viatris has delivered a 76.1% gain over the last 12 months, which makes it important to ask whether the current price already reflects much of the good news.
The recent FDA approval for the once weekly Gwyn Lo contraceptive patch...